with M&G USA Corp. and its affiliated debtors (“M&G”) to acquire the integrated PTA-PET plant currently under construction in Corpus Christi, Texas (the “Corpus Christi Project”), along with certain M&G
for certain period as the negotiation by the parties for conclusion of the shareholders agreement required as a condition precedent has not yet completed. The terms of the shareholders agreement being
would like to inform that the Company has extended the completion of the acquisition of 8,181 shares in Aukkarawat, equivalent to 16.36 percent of the total issued shares of Aukkarawat for certain period
October 31, 2017 (the “Transaction Completion”). The Company would like to clarify that the Transaction Completion will be extended for certain period as material conditions precedent required under the
(2003) which contains certain provisions in relation to the restriction of rights and liberty of persons which Section 29, in conjunction with Section 33, Section 34, Section 36, Section 41, Section 43
(2003) as amended by the Derivatives Act (No. 2) B.E. 2551 (2008) which contains certain provisions in relation to the restriction of rights and liberty of persons which Section 29, in conjunction with
. 2546 (2003) which contain certain provisions in relation to the restriction of rights and liberties of persons which Section 29 in conjunction with Section 33, Section 34, Section 36, Section 41, Section
and Section 19 of the Derivatives Act B.E. 2546 (2003) which contain certain provisions in relation to the restriction of rights and liberties of persons which Section 29 in conjunction with Section 33
Securities and Exchange Act, B.E. 2535 (1992) as amended by the Securities and Exchange Act (No. 4), B.E. 2551 (2008), which contain certain provisions in relation to the restriction of rights and liberties of